Archer-Daniels-Midland Company (ADM) drops after deep earnings
Archer-Daniels-Midland Company (ADM) beat EPS expectations and lifted guidance, but shares fell as revenue missed estimates and investors weighed the durability of margin gains. This deep-dive breaks down segment performance, cash generation concerns, and why strong profits still failed to support the stock.
Archer-Daniels-Midland Company (ADM) posted a strong third-quarter earnings beat, with adjusted EPS of $1.77 versus $1.60 expected, and raised full-year 2026 guidance to $5.50-$5.80. But revenue came in below consensus at $22.34 billion, and investors sold the stock on concerns about free cash flow quality and the sustainability of biofuel-driven margins. For investors, the report was fundamentally positive on profit but mixed on durability, which helps explain the sharp post-earnings decline.
Archer-Daniels-Midland Company (ADM) drops on earnings
Archer-Daniels-Midland Company (ADM) delivered a sharp third-quarter EPS beat and raised its full-year outlook, but the revenue miss pulled shares lower. ADM stock drops 7.25% to $70.28 in Nov. 3 regular trading, even as adjusted EPS reached $1.77 versus the $1.60 consensus estimate.
The split between earnings and revenue explains the market reaction. ADM produced stronger profits from crushing, ethanol and biodiesel, while investors questioned the durability of those gains and the quality of cash generation.
Key Takeaways
Adjusted EPS was $1.77, above the $1.60 estimate. Revenue reached $22.34B, below the $23.27B consensus.
Ag Services and Oilseeds led segment profit growth with $778M, up 105% year over year. Crushing contributed $311M, roughly $300M above the prior-year quarter.
Carbohydrate Solutions operating profit rose 40% to $470M as ethanol margins benefited from policy incentives and stronger demand.
ADM raised full-year 2026 adjusted EPS guidance to $5.50-$5.80 from $5.15-$5.60.
Nutrition revenue fell 4% to $1.8B, but segment operating profit increased 3% to $134M. Animal Nutrition profit rose 21% to $41M.
The analyst consensus remains Hold, with 12 Buy ratings, 22 Holds and 2 Sells. JPMorgan remains Underweight with a $75 price target.
This Archer-Daniels-Midland Company earnings analysis starts with the headline profit result. ADM reported adjusted EPS of $1.77 for the third quarter of 2026, compared with $1.60 expected. That marked a strong improvement from adjusted EPS of $0.92 in the prior-year quarter, although it trailed the $1.84 recorded in the second quarter of 2026.
Revenue tells a different story. ADM posted $22.34B, versus $23.27B expected and $20.372B in the prior-year quarter. Net income was $0.82B. The result shows that ADM converted favorable operating conditions into profit, but did not meet the top-line target set by analysts.
Total segment operating profit reached $1.4B, up 64% from the prior-year quarter. Ag Services and Oilseeds supplied the largest contribution at $778M, up 105%. Ag Services itself produced $172M, down 9%, as stronger U.S. corn and soybean exports partly offset weaker results in markets such as Ukraine.
The major swing factor was crushing. Operating profit climbed to $311M, roughly $300M above the prior-year quarter. ADM cited a favorable North American biofuels margin environment, stronger soybean meal demand and higher global crush volumes. Global crush volumes increased 1.6% year over year, while South American soybean crush volumes reached a quarterly record.
Refined Products and Other added $218M, up 82% year over year. Higher North American biodiesel margins supported the gain, along with favorable mark-to-market and timing effects. ADM reported $35M of net positive mark-to-market and timing impacts within Ag Services and Oilseeds. Refined Products and Other accounted for about $45M of that benefit.
Carbohydrate Solutions also delivered a meaningful contribution. Segment operating profit rose 40% to $470M. Starches and Sweeteners produced $324M, up 11%, while Vantage Corn Processors contributed $146M, a $103M improvement from the prior-year quarter. Strong ethanol margins and policy incentives more than offset pressure in liquid sweeteners.
Nutrition remained a mixed picture. Revenue declined 4% to $1.8B, with Human Nutrition revenue down 2% and Animal Nutrition revenue down 6%. Still, segment operating profit increased 3% to $134M. Human Nutrition profit fell 3% to $93M, while Animal Nutrition profit rose 21% to $41M after portfolio actions and operating improvements.
Cash generation adds another layer to the ADM earnings story. The company generated about $3B in cash flow from operations before working capital changes during the first nine months. However, post-earnings market commentary focused on roughly breakeven free cash flow in the quarter and a 6.6 percentage-point year-over-year decline in cash profitability.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
ADM shares fell from a prior close of $75.77 to $70.28 during the first regular session after the earnings report. The 7.25% decline came with volume of 3,032,904 shares, below the reported average of 3,424,696.
The selloff shows that a beat does not automatically earn investor approval. Market commentary centered on the $22.34B revenue miss, the quality of free cash flow and concern that favorable biofuel margins could be difficult to sustain. In plain English, the market accepted the earnings number but challenged the engine behind it.
The broader analyst consensus remains Hold. The rating mix includes 12 Buys, 22 Holds and 2 Sells, with no Strong Buy or Strong Sell ratings. That distribution points to a divided view of ADM's earnings durability rather than a broad bullish reset.
JPMorgan maintained an Underweight rating and cut its price target to $75 from $77 on Oct. 12, before the report. The bank's stance reflects caution around ADM's margin cycle and earnings durability. By contrast, Barclays carries an Equal-Weight rating with a $90 target, raised from $85, while BMO Capital has a Market Perform rating and an $82 target, raised from $77 on Aug. 5.
Those targets show the central disagreement. JPMorgan values ADM near the pre-report closing level, while Barclays and BMO assign more value to the company's improved operating results and longer-term growth plans. The stock's immediate drop favors the cautious camp.
CEO Juan Luciano framed the quarter around execution in a difficult operating environment. He pointed to elevated global energy prices, favorable biofuel margins and improving Nutrition results. His guidance update also gave investors a clear financial marker for the rest of 2026.
"Given our strong performance year-to-date and our outlook for the remainder of the fourth quarter, we are again raising our full year 2026 adjusted EPS guidance. We now expect a range of $5.50 to $5.80 for adjusted EPS, an increase from our prior range of $5.15 to $5.60." - Juan Luciano, Chair and CEO, ADM earnings call
"Throughout this year, our substantial crushing, ethanol and biodiesel footprints have given us tremendous access to a favorable North American margin environment and have been a true competitive advantage." - Juan Luciano, Chair and CEO, ADM earnings call
That second point matters because crushing and refined products produced much of the quarter's profit growth. ADM also resumed opportunistic share repurchases and paid its 379th consecutive quarterly dividend, actions that management linked to balance-sheet health and shareholder returns.
CFO Monish Patolawala supplied the segment detail behind the headline beat. His comments show that the result relied on several distinct operating gains, rather than a single accounting item.
"AS&O segment operating profit for the third quarter of 2026 was $778 million, up 105% compared to the prior year quarter." - Monish Patolawala, CFO, ADM earnings call
"For the first 9 months of the year, ADM generated cash flow from operations before working capital of approximately $3 billion." - Monish Patolawala, CFO, ADM earnings call
Luciano also highlighted longer-term growth initiatives. ADM is targeting $80M to $100M of annual operating profit uplift over time from natural colors in Nutrition. In Carbohydrate Solutions, the company is developing precision fermentation products for pet food, baked goods, dairy and food manufacturing.
The company also plans a joint venture with CJ that combines ADM's Decatur, Illinois, amino acid facility with selected CJ assets. Management said the structure addresses pressure on U.S. feed-grade amino acid production, especially lysine. These projects offer a more durable growth narrative, but the third-quarter numbers still came primarily from biofuel-related margins.
Bottom Line
ADM's $1.77 adjusted EPS and higher $5.50-$5.80 full-year guidance confirm strong near-term earnings momentum. Still, the $22.34B revenue miss, cash-flow concerns and 7.25% share-price drop show that investors want proof that biofuel-driven gains can last.
The investment case now rests on two forces: continued strength in crushing and ethanol, plus execution in Nutrition, natural colors and precision fermentation. ADM has improved the numbers, but the market is demanding a higher-quality growth story.
+Why did ADM stock fall after earnings even though it beat EPS?
ADM shares fell 7.25% to $70.28 because revenue missed expectations at $22.34 billion versus $23.27 billion expected. Investors also focused on concerns about free cash flow quality and whether the strong biofuel margins can last.
+What were Archer-Daniels-Midland's Q3 2026 earnings and revenue results?
ADM reported adjusted EPS of $1.77, ahead of the $1.60 consensus estimate. Revenue was $22.34 billion, below the $23.27 billion consensus and up from $20.372 billion a year earlier.
+Which ADM business segments drove the earnings beat?
Ag Services and Oilseeds led with segment profit of $778 million, up 105% year over year, while crushing profit rose to $311 million. Carbohydrate Solutions also helped, with operating profit up 40% to $470 million on stronger ethanol margins and policy incentives.
+Did ADM raise its full-year guidance after the quarter?
Yes, ADM raised its full-year 2026 adjusted EPS guidance to $5.50-$5.80 from $5.15-$5.60. The company also reported that Nutrition revenue fell 4% to $1.8 billion, even though segment operating profit still increased 3% to $134 million.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌The Full Report
Want the full picture on ADM?
The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.